Intellektualniy Dialog Overview

  • Founded
  • 2006
  • Status
  • Out of Business
  • Latest Deal Type
  • Out of Business

Intellektualniy Dialog General Information


Developer of drugs designed to conduct research and develop innovative targeted drugs that have antiviral activity against the hepatitis C virus. The company's products are a selective inhibitor of the NS5A protein of the hepatitis C virus, with tolerability and a favorable safety profile, enabling physicians to treat the patient without any side effects.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Primary Office
  • Working street, 2a, building 1
  • Khimki
  • Moscow, 141400
  • Russia
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Intellektualniy Dialog Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 01-Nov-2018 000 Completed Out of Business
1. Seed Round 01-Jan-2007 000 000 Completed Startup
To view Intellektualniy Dialog’s complete valuation and funding history, request access »